{"transactions":[{"id":1824008,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:45:59.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009598","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009598/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824672,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:33.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009529","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009529/section16.xml","form_type":"4"}},{"id":2347193,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-03-08T00:40:53.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the Grant Date."}],"balance_after":11000,"derivative":{"exercise_price":3.71,"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001654954-22-002655","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422002655/section16.xml","form_type":"4"}},{"id":2739371,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T20:49:24.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the Grant Date."}],"balance_after":20000,"derivative":{"exercise_price":5.45,"expiration_date":"2031-04-22","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-21-004624","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495421004624/section16.xml","form_type":"4"}},{"id":2849003,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2021-02-19T00:40:25.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":6165,"price":7.25,"value":44696.25,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001654954-21-001837","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495421001837/section16.xml","form_type":"4"}},{"id":2849002,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2021-02-19T00:40:25.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1827,"price":7.25,"value":13245.75,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001654954-21-001837","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495421001837/section16.xml","form_type":"4"}},{"id":2994249,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-11-03T20:33:18.000Z","date":"2020-10-06","kind":"other","acquired":false,"shares":609,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":609},"source":{"system":"sec-edgar","filing":"0001654954-20-011793","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420011793/section16.xml","form_type":"4"}},{"id":2994248,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2020-11-03T20:33:18.000Z","date":"2020-10-06","kind":"other","acquired":true,"shares":609,"price":4,"value":2436.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":1827,"source":{"system":"sec-edgar","filing":"0001654954-20-011793","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420011793/section16.xml","form_type":"4"}},{"id":3006847,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2020-10-14T19:57:06.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":20000,"derivative":{"exercise_price":7.44,"expiration_date":"2030-10-13","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-20-011150","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420011150/section16.xml","form_type":"4"}},{"id":3269948,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2020-02-14T23:19:56.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested"}],"balance_after":11389,"derivative":{"exercise_price":3.16,"expiration_date":"2030-02-12","underlying":"Common Shares","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001654954-20-001655","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420001655/section16.xml","form_type":"4"}},{"id":3313100,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-11T02:42:07.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":609,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":609,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":609},"source":{"system":"sec-edgar","filing":"0001654954-20-000313","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000313/section16.xml","form_type":"4"}},{"id":3313099,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-11T02:42:07.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":914,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":914,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":914},"source":{"system":"sec-edgar","filing":"0001654954-20-000313","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000313/section16.xml","form_type":"4"}},{"id":3313098,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2020-01-11T02:42:07.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":1218,"price":4.11,"value":5005.98,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":1218,"source":{"system":"sec-edgar","filing":"0001654954-20-000313","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420000313/section16.xml","form_type":"4"}},{"id":3414747,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2019-09-13T20:24:04.000Z","date":"2019-09-11","kind":"sale","acquired":false,"shares":1809,"price":5.7187,"value":10345.1283,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."}],"balance_after":6165,"source":{"system":"sec-edgar","filing":"0001654954-19-010741","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495419010741/section16.xml","form_type":"4"}},{"id":3601286,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Shares, without par value","published_at":"2019-03-11T21:31:30.000Z","date":"2019-03-06","kind":"sale","acquired":false,"shares":4000,"price":1.2501,"value":5000.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":47924,"source":{"system":"sec-edgar","filing":"0001144204-19-013348","document":"tv515980_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420419013348/tv515980_4.xml","form_type":"4"}},{"id":3791735,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Shares, without par value","published_at":"2018-10-13T01:49:38.000Z","date":"2018-10-12","kind":"sale","acquired":false,"shares":3000,"price":1.31,"value":3930.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share."}],"balance_after":51924,"source":{"system":"sec-edgar","filing":"0001144204-18-053712","document":"tv504784_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420418053712/tv504784_4.xml","form_type":"4"}},{"id":3995903,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Share Option (Right to Buy)","published_at":"2018-03-15T00:20:39.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2019 and as to the remaining one-third on September 12, 2019."}],"balance_after":40000,"derivative":{"exercise_price":0.84,"expiration_date":"2025-03-12","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001144204-18-014752","document":"tv488520_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420418014752/tv488520_4.xml","form_type":"4"}},{"id":4270916,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Shares, without par value","published_at":"2017-06-28T20:45:54.000Z","date":"2017-06-26","kind":"grant","acquired":true,"shares":235690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued under the issuer's Performance Share Plan."}],"balance_after":384467,"source":{"system":"sec-edgar","filing":"0001144204-17-034655","document":"v469936_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420417034655/v469936_4.xml","form_type":"4"}},{"id":4491778,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":111184,"kind":"person","name":"OAKES FRANK R.","position":1,"cik":"0001620188","reported_name":"OAKES FRANK R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Shares, without par value","published_at":"2017-01-12T21:35:52.000Z","date":"2017-01-12","kind":"gift","acquired":false,"shares":40188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":148777,"source":{"system":"sec-edgar","filing":"0001144204-17-002015","document":"v456838_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000114420417002015/v456838_4.xml","form_type":"4"}}]}